摘要
目的分析采取舒利迭治疗中重度稳定期的慢性阻塞性肺疾病患者的疗效及安全性。方法选取我院2010年10月至2011年10月收治的中重度稳定期慢性阻塞性肺疾病患者50例,随机分成观察组和对照组,对照组采取常规治疗。观察组在此基础上对中重度稳定期慢性阻塞性肺疾病患者使用舒利迭。结果观察组总有效率明显高于对照组,差异具有显著性,有统计学意义(P<0.05)。结论采取舒利迭治疗稳定期中重度慢性阻塞性肺疾病患者的疗效更好,安全性更高,不良反应少,可减少死亡率的发生。
Objective To analyze the efficacy and safety of seretide in the treatment of patients with moderate to severe chronic obstructive pulmonary disease at steady period. Methods Fifty patients with moderate to severe chronic obstructive pulmonary disease at steady period in our hospital from October 2010 to October 2011 were selected and randomly divided into observation group and control group. The control group adopted conventional treatment, while the observation group received seretide for the patients with moderate to severe chronic obstructive pulmonary disease at steady period on the basis of conventional treatment. Results The total effective rate in the observation group was significantly higher than that of the control group, and the difference was statistically significant （P 〈0.05）. Conclusions The use of seretide in the treatment of patients with chronic obstructive pulmonary disease at steady period has better curative effect, higher safety, less adverse reactions, which can reduce the occurrence of mortality.
出处
《临床医学工程》
2013年第1期59-60,共2页
Clinical Medicine & Engineering
关键词
舒利迭
中重度稳定期慢性阻塞性肺疾病
疗效
Seretide
Moderate to severe chronic obstructive pulmonary disease at steady period
Therapeutic effect
